MARKET

SRDX

SRDX

Surmodics
NASDAQ

Real-time Quotes | Nasdaq Last Sale

33.50
+0.35
+1.06%
Opening 09:40 04/02 EDT
OPEN
33.38
PREV CLOSE
33.15
HIGH
33.50
LOW
33.38
VOLUME
1.27K
TURNOVER
--
52 WEEK HIGH
49.00
52 WEEK LOW
22.06
MARKET CAP
455.27M
P/E (TTM)
71.75
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average SRDX stock price target is 60.67 with a high estimate of 76.00 and a low estimate of 50.00.

EPS

SRDX News

More
  • Here's Why You Should Add Surmodics to Your Portfolio Now
  • Zacks · 1h ago
  • Why Surmodics, Inc.'s (NASDAQ:SRDX) CEO Pay Matters To You
  • Simply Wall St. · 03/21 15:54
  • The Daily Biotech Pulse: Setback For DBV In Peanut Allergy Patch Review, Roche Starts Coronavirus Test Shipment, Regeneron Aims For 'Cocktail' COVID-19 Treatment
  • Benzinga · 03/17 15:38
  • The Daily Biotech Pulse: Roche Obtains FDA Emergency Use Authorization For COVID-19 Test, Chembio Appoints New CEO, Inovio Slumps On Earnings
  • Benzinga · 03/13 11:52

Industry

Medical Equipment, Supplies & Distribution
+0.17%
Healthcare Equipment & Supplies
+0.47%

Hot Stocks

Symbol
Price
%Change

About SRDX

Surmodics, Inc. is a provider of medical device and in vitro diagnostic technologies to the healthcare industry. The Company operates through two segments: Medical Device and In Vitro Diagnostics. The Company's Medical Device segment consists of surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices; international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device. The Company's In Vitro Diagnostics segment manufactures or sells components for in vitro diagnostic immunoassay and molecular tests. The In Vitro Diagnostics segment manufactures and sells surface coatings to the diagnostic, biomedical research and life science markets. In Vitro Diagnostics segment offers protein stabilization reagents, substrates, antigens and surface coatings.
More

Webull offers kinds of SurModics, Inc. stock information, including NASDAQ:SRDX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SRDX stock news, and many more online research tools to help you make informed decisions.